Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

Does FLUOROURACIL Cause Disease progression? 2,377 Reports in FDA Database

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

According to the FDA Adverse Event Reporting System (FAERS), 2,377 reports of Disease progression have been filed in association with FLUOROURACIL (FLUOROURACIL). This represents 4.5% of all adverse event reports for FLUOROURACIL.

2,377
Reports of Disease progression with FLUOROURACIL
4.5%
of all FLUOROURACIL reports
596
Deaths
335
Hospitalizations

How Dangerous Is Disease progression From FLUOROURACIL?

Of the 2,377 reports, 596 (25.1%) resulted in death, 335 (14.1%) required hospitalization, and 73 (3.1%) were considered life-threatening.

Is Disease progression Listed in the Official Label?

This adverse event is not currently listed in the official FDA drug label for FLUOROURACIL. However, 2,377 reports have been filed with the FAERS database.

What Other Side Effects Does FLUOROURACIL Cause?

Diarrhoea (5,373) Neutropenia (4,400) Nausea (3,757) Vomiting (2,836) Off label use (2,788) Neuropathy peripheral (2,605) Thrombocytopenia (2,426) Fatigue (2,421) Febrile neutropenia (2,230) Anaemia (2,169)

What Other Drugs Cause Disease progression?

RITUXIMAB (7,282) CYCLOPHOSPHAMIDE (7,100) DOXORUBICIN (6,165) VINCRISTINE (5,252) PREDNISONE (5,096) BEVACIZUMAB (4,653) DEXAMETHASONE (4,545) CARBOPLATIN (4,538) CAPECITABINE (3,808) ETOPOSIDE (3,776)

Which FLUOROURACIL Alternatives Have Lower Disease progression Risk?

FLUOROURACIL vs FLUOROURACIL\IRINOTECAN\LEUCOVORIN FLUOROURACIL vs FLUOROURACIL\IRINOTECAN\LEUCOVORIN\OXALIPLATIN FLUOROURACIL vs FLUOROURACIL\LEUCOVORIN\OXALIPLATIN FLUOROURACIL vs FLUOXETINE FLUOROURACIL vs FLUOXETINE\FLUOXETINE

Related Pages

FLUOROURACIL Full Profile All Disease progression Reports All Drugs Causing Disease progression FLUOROURACIL Demographics